New factor XIa inhibitors cut recurrent non-cardioembolic stroke without extra bleeding—plus what milvexian and abilacimab trials reveal. In this installment of this series, ‘The Future of Factor XIa ...
The non-random distribution of transposable elements (TEs) in eukaryotic genomes is the consequence of both TE integration site preferences and post-integration selection processes. Next-generation ...
Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model A novel Fixed-Stratified method was developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results